In vitro and in vivo Pharmacological Activities of 14-O-Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice

Overview of attention for article published in Frontiers in Pharmacology, August 2018

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 21 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 9 publications that cite this research output.

9

The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.

Peripheralization Strategies Applied to Morphinans and Implications for Improved Treatment of Pain

Article in Molecules (June 2023)

CYX-5, a G-protein biassed MOP receptor agonist, DOP receptor antagonist and KOP receptor agonist, evokes constipation but not respiratory depression relative to morphine in rats

Article in Pharmacological Reports (January 2023)

A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse

Article in European Journal of Medicinal Chemistry (September 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.